ALLMedicine™ Pemphigus Center

May 20th, 2022 - Anticytokine autoantibodies are an important and emerging cause of disease. Anticytokine autoantibody-associated diseases include disseminated nontuberculous mycobacterial infection caused by anti-interferon- >= autoantibodies, severe mucocutaneou...

May 16th, 2022 - Pemphigus Vulgaris after COVID-19 Infection and Vaccination.|2022|Zou H,Daveluy S,|

May 6th, 2022 - Some pathways involved in the pathogenesis of psoriasis share similarities with processes involved in multiple sclerosis (MS) pathogenesis. However, the association between MS and psoriasis is poorly understood. Since disease-modifying therapies f...

May 5th, 2022 - This study determines the healing time of lesions on different locations and the contributing factors to the healing time in patients with pemphigus. In this prospective study, newly diagnosed patients with mucosal lesions were included. A dermato...

Apr 27th, 2022 - Pemphigus vulgaris (PV) is an autoimmune bullous skin disease. Aquaporin 3 (AQP3) is a glycerol/water channel involved in several physiological functions. Evaluation of the tissue expression and localization of AQP3 in the skin of PV patients. Twe...

Dec 2nd, 2017 - British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.|2017|Harman KE,Brown D,Exton LS,Groves RW,Hampton PJ,|administration & dosage,therapy,methods,therapeutic use,therapeutic use,diagnosis,therapy,method...

Oct 24th, 2014 - Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due ...

Jun 10th, 2014 - The Committee for Guidelines for the Management of Pemphigus was organized as one element of the Japanese Dermatological Association (JDA) and the Ministry of Health, Labour, and Welfare (MHLW) Research Project on Measures for Research Committee f...

May 20th, 2022 - Anticytokine autoantibodies are an important and emerging cause of disease. Anticytokine autoantibody-associated diseases include disseminated nontuberculous mycobacterial infection caused by anti-interferon- >= autoantibodies, severe mucocutaneou...

Mar 31st, 2022 - The background therapy is based on prednisolone administration. PV is a rare disorder, therefore this study is designed as a crossover that may require fewer patients than a parallel study. The study enrolled participants with moderate-to-severely...

Nov 22nd, 2021 - Up to 12 adults between the ages of 18 and 75 years of age who have been diagnosed with pemphigus and meet all other entry criteria will be enrolled to receive one infusion of their own expanded Tregs at one of the following doses: 1.0 x 10^8 Poly...

Oct 8th, 2021 - This was a non-confirmatory, randomized, partial-blind, placebo-controlled trial evaluating the efficacy, safety and pharmacokinetics (PK) of VAY736 in the treatment of PV patients. A total of 13 patients were enrolled and randomized into the stud...

Jan 8th, 2021 - Pemphigus is a rare autoimmune disease involving skin and mucous membranes with an incidence estimated as 0.7 to 7 new cases per million per year, responsible for non-negligible morbidity and mortality. Pemphigus is characterized by the production...

Mar 31st, 2022 - For patients presenting with moderate to severe pemphigus, the choice of initial therapy has been distilled to a single agent: rituximab. This drug is more rapidly effective, more likely to provide sustained remission, better tolerated, and lowers...

Mar 10th, 2022 - White-to-pink friable plaques occurring acutely in the vulva is concerning for one form of secondary syphilis that affects mucous membranes: condyloma lata. Known as the great imitator for its variety of clinical presentations, syphilis is a sexua.

Sep 30th, 2021 - This patient was given a diagnosis of linear IgA bullous dermatosis (LABD) based on biopsy results. (Biopsy is extremely helpful in differentiating bullous disorders.

Aug 31st, 2021 - The Diagnosis: Pemphigus Foliaceous Laboratory workup including a complete blood cell count with differential, comprehensive metabolic panel, antinuclear antibodies, Sjögren syndrome A and B antibodies, hepatitis profile, rapid plasma reagin, HIV.

Aug 30th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. In the wake of the Centers for Disease Control and Prevention’s recommendation for a third COVID-19 mRNA vaccine dose for immunocompromised people...